Hillhurst Biopharmaceuticals, Inc.
Clinical trials sponsored by Hillhurst Biopharmaceuticals, Inc., explained in plain language.
-
Could carbon monoxide be a medicine? new trial for sickle cell
Disease control Recruiting nowThis early-stage trial tests an oral liquid containing carbon monoxide (HBI-002) in 9 people with sickle cell disease, aged 14-55. The goal is to see if it is safe and how the body processes it when taken daily for 14 days. This is not a cure but aims to control the disease by re…
Phase: PHASE1, PHASE2 • Sponsor: Hillhurst Biopharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Could carbon monoxide help Parkinson's? new trial launches
Symptom relief Recruiting nowThis study tests an experimental oral liquid called HBI-002, which contains a low dose of carbon monoxide, in 36 adults with Parkinson's disease. Participants take the liquid daily for 14 days to see if it is safe and tolerable. The goal is to gather early information on how the …
Phase: PHASE2 • Sponsor: Hillhurst Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 26, 2026 04:36 UTC